Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacillus Subtilis and Enterococcus Faecium in Hypertriglyceridemic Acute Pancreatitis
NCT07720232Phase 4Recruiting
- Sponsor
- Jianyin Zhou
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 4 trial of Medilac-S in Hypertriglyceridemic acute pancreatitis (HTGP), sponsored by Jianyin Zhou. Started Jan 2026; status: recruiting.
02
Drugs
Medilac-S
03
Conditions
Hypertriglyceridemic acute pancreatitis (HTGP)
Beyond the preview
Go deeper on NCT07720232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07720232.